New Research Calls Impacting Investors on Wall Street

Today's Important Research Calls

The most talked-about and impactful research calls on Wall Street are now all in one place. We have compiled important calls that investors need to pay attention to in order to make informed decisions.

Jefferies upgraded its rating on DoorDash (DASH) from Hold to Buy and raised the price target to $260. The firm believes it is necessary to take a more positive stance towards DoorDash as a result of the rapid growth observed in US restaurant deliveries over the last four quarters.

Nomura upgraded its rating on Baidu (BIDU) from Neutral to Buy and raised the price target from $135 to $140. The company noted the "significant growth potential" of Kunlunxin, the chip design subsidiary in which Baidu holds a 69% stake, and that management is considering enhancing capital returns.

UBS upgraded its rating on Insulet (PODD) from Neutral to Buy and raised the price target from $355 to $400. The firm believes the company has the potential to maintain its growth momentum by the end of the decade.

Jefferies upgraded its rating on Zions Bancorp (ZION) from Hold to Buy and raised the price target from $55 to $60. They highlighted that the concerns over the "mini credit fear" and fraud-related charges in the third quarter have been exaggerated.

Goldman Sachs upgraded its rating on Medtronic (MDT) from Sell to Neutral and raised the price target from $81 to $111. Following the second quarter results, the company noted an increase in the momentum of new products and an improvement in overall P&L metrics.

Wells Fargo downgraded Molson Coors (TAP) from Overweight to Equal Weight and lowered the price target from $53 to $50. Molson is facing category weakness along with share losses and "tight" cost pressures.

Mizuho downgraded Canadian Solar (CSIQ) from Outperform to Underperform and raised the price target from $15 to $21. They noted the uncertainty regarding the impact of developments related to the US factory.

BofA downgraded BellRing Brands (BRBR) from Buy to Neutral and lowered the price target from $50 to $28. They cited the "weak" fourth quarter results, the discrepancy in the FY26 outlook, and cuts to the company's long-term sales algorithm as reasons for this decision.

HSBC downgraded QuantumScape (QS) from Hold to Reduce and increased the price target from $5.30 to $10.50. While the company has made some significant deals, it warned investors about the lack of transparency in contract economics.

Truist downgraded GitLab (GTLB) from Buy to Hold and reduced the price target from $55 to $44. They indicated that the company's business model transition may face visibility challenges and high execution risk.

Wells Fargo initiated coverage of AB InBev (BUD) with an Overweight rating and a price target of $75. They noted AB InBev's "cheap" valuation and an optimistic outlook leading up to the 2026 World Cup.

Citizens JMP initiated coverage of Riot Platforms (RIOT) with an Outperform rating and a price target of $25. The firm aims to provide critically scarce energy supplies for high-performance computing and artificial intelligence through five bitcoin mining companies.

BofA initiated coverage of Extreme Networks (EXTR) with a Buy rating and a price target of $24. They emphasized that there is a WiFi-7 upgrade cycle that could double the cloud-based campus network solutions provider's growth forecasts.

Canaccord initiated coverage of Insight Enterprises (NSIT) with a Hold rating and a price target of $100. They indicated that the company's transition from a commodity IT reseller to a solution-focused technology partner is at a good point.

UBS initiated coverage of Parsons (PSN) with a Buy rating and a price target of $107. They noted that growth will accelerate due to a technology-focused M&A strategy supported by strong order flows, and that margins between the two segments will widen.